Wenjuan Mei

577 total citations
35 papers, 466 citations indexed

About

Wenjuan Mei is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Nephrology. According to data from OpenAlex, Wenjuan Mei has authored 35 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Nephrology. Recurrent topics in Wenjuan Mei's work include Prostate Cancer Treatment and Research (9 papers), Chronic Kidney Disease and Diabetes (6 papers) and Renal Diseases and Glomerulopathies (6 papers). Wenjuan Mei is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Chronic Kidney Disease and Diabetes (6 papers) and Renal Diseases and Glomerulopathies (6 papers). Wenjuan Mei collaborates with scholars based in China, Canada and United States. Wenjuan Mei's co-authors include Damu Tang, Yan Gu, Xiaozeng Lin, Anil Kapoor, Lijian Tao, Zhangzhe Peng, Qiongjing Yuan, Gaoyun Hu, Ling Huang and Yanyun Xie and has published in prestigious journals such as PLoS ONE, Journal of Business Research and Journal of Business Ethics.

In The Last Decade

Wenjuan Mei

32 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenjuan Mei China 14 257 127 103 81 55 35 466
Suresh Guruswamy United States 11 411 1.6× 66 0.5× 54 0.5× 140 1.7× 20 0.4× 16 608
Qiang Dang China 14 318 1.2× 192 1.5× 187 1.8× 135 1.7× 7 0.1× 26 611
Guangquan Xu China 8 495 1.9× 82 0.6× 323 3.1× 57 0.7× 18 0.3× 10 641
Marilena Crescimanno Italy 13 233 0.9× 58 0.5× 106 1.0× 126 1.6× 34 0.6× 16 483
Daniel Mathow Germany 9 174 0.7× 27 0.2× 46 0.4× 44 0.5× 54 1.0× 11 348
Nelson E. Bruno United States 14 202 0.8× 80 0.6× 59 0.6× 85 1.0× 14 0.3× 18 561
Kelly Mundy United States 8 140 0.5× 137 1.1× 54 0.5× 94 1.2× 21 0.4× 14 330
Zhenyuan Yu China 9 318 1.2× 137 1.1× 106 1.0× 68 0.8× 38 0.7× 17 530
Xiaowen Zhang China 12 432 1.7× 52 0.4× 291 2.8× 45 0.6× 14 0.3× 22 548

Countries citing papers authored by Wenjuan Mei

Since Specialization
Citations

This map shows the geographic impact of Wenjuan Mei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjuan Mei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjuan Mei more than expected).

Fields of papers citing papers by Wenjuan Mei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenjuan Mei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjuan Mei. The network helps show where Wenjuan Mei may publish in the future.

Co-authorship network of co-authors of Wenjuan Mei

This figure shows the co-authorship network connecting the top 25 collaborators of Wenjuan Mei. A scholar is included among the top collaborators of Wenjuan Mei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenjuan Mei. Wenjuan Mei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mei, Wenjuan, et al.. (2025). Differential contributions of the ryanodine receptor I4723M and I4723K mutations to diamide resistance in Spodoptera litura. Pesticide Biochemistry and Physiology. 208. 106292–106292. 3 indexed citations
2.
Zheng, Linfeng, Wenjuan Mei, Jing Zhou, et al.. (2024). Fluorofenidone attenuates renal fibrosis by inhibiting lysosomal cathepsin‑mediated NLRP3 inflammasome activation. Experimental and Therapeutic Medicine. 27(4). 142–142.
3.
Shi, Yu, et al.. (2024). F116I mutation in CYP9A25 associated with resistance to emamectin benzoate in Spodoptera litura. Pest Management Science. 81(1). 247–254. 3 indexed citations
4.
5.
Wei, Shan, Wenjuan Mei, & Ying Wang. (2024). Association of thrombotic microangiopathy with interferon therapy for hepatitis B: a case report. Journal of Medical Case Reports. 18(1). 321–321.
6.
Mei, Wenjuan, et al.. (2024). Unethical Behavior in the Name of the Family: Exploring the Consequences of Unethical Pro-Family Behavior on Employees’ Work and Life. Journal of Business Ethics. 197(3). 505–522. 4 indexed citations
7.
Yan, Yan, Qian Wu, Jinhong Li, et al.. (2023). Chitosan inhibits vascular intimal hyperplasia via LINC01615/MIR-185-5p/PIK3R2 signaling pathway. Gene. 892. 147850–147850. 1 indexed citations
8.
Mei, Wenjuan, et al.. (2023). From self-avoidance to help others: Exploring why and when feedback avoiding behavior promotes volunteering. Journal of Business Research. 166. 114117–114117. 2 indexed citations
9.
Mei, Wenjuan, Ying Dong, Yan Gu, et al.. (2023). IQGAP3 is relevant to prostate cancer: A detailed presentation of potential pathomechanisms. Journal of Advanced Research. 54. 195–210. 5 indexed citations
10.
Gu, Yan, Lizhi He, Xiaozeng Lin, et al.. (2021). Prognostic and Therapeutic Potential of the OIP5 Network in Papillary Renal Cell Carcinoma. Cancers. 13(17). 4483–4483. 5 indexed citations
11.
12.
Mei, Wenjuan, et al.. (2019). The Contributions of Prostate Cancer Stem Cells in Prostate Cancer Initiation and Metastasis. Cancers. 11(4). 434–434. 87 indexed citations
13.
Gu, Yan, Anil Kapoor, Wenjuan Mei, et al.. (2018). Biphasic Alteration of Butyrylcholinesterase (BChE) During Prostate Cancer Development. Translational Oncology. 11(4). 1012–1022. 20 indexed citations
14.
Mei, Wenjuan, Yan Gu, Yanzhi Jiang, Pierre Major, & Damu Tang. (2018). Circulating cell-free DNA is a potential prognostic biomarker of metastatic castration-resistant prostate cancer for taxane therapy. AME Medical Journal. 3. 68–68. 4 indexed citations
15.
Tang, Juan, Chunyan Liu, Miaomiao Lu, et al.. (2015). Fluorofenidone protects against renal fibrosis by inhibiting STAT3 tyrosine phosphorylation. Molecular and Cellular Biochemistry. 407(1-2). 77–87. 21 indexed citations
16.
Lu, Miaomiao, Wenjun Yang, Zhangzhe Peng, et al.. (2015). Fluorofenidone inhibits macrophage IL-1β production by suppressing inflammasome activity. International Immunopharmacology. 27(1). 148–153. 15 indexed citations
17.
Liu, Chunyan, Wenjuan Mei, Juan Tang, et al.. (2015). Mefunidone Attenuates Tubulointerstitial Fibrosis in a Rat Model of Unilateral Ureteral Obstruction. PLoS ONE. 10(6). e0129283–e0129283. 31 indexed citations
18.
Lu, Miaomiao, Wenjuan Mei, Renna Luo, et al.. (2014). [Effect of curcumin on the expression of p-STAT3 and IκB in db/db mice].. PubMed. 39(6). 591–7. 6 indexed citations
19.
Li, Ruixin, Weijie Yuan, Wenjuan Mei, Keda Yang, & Zihua Chen. (2014). MicroRNA 520d-3p inhibits gastric cancer cell proliferation, migration, and invasion by downregulating EphA2 expression. Molecular and Cellular Biochemistry. 396(1-2). 295–305. 39 indexed citations
20.
Mei, Wenjuan, Yanyun Xie, Jishi Liu, et al.. (2014). Fluorofenidone Offers Improved Renoprotection at Early Interventions during the Course of Diabetic Nephropathy in db/db Mice via Multiple Pathways. PLoS ONE. 9(10). e111242–e111242. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suresh Guruswamy Breakdown of academic impact, for papers by Qiang Dang Breakdown of academic impact, for papers by Guangquan Xu Breakdown of academic impact, for papers by Marilena Crescimanno Breakdown of academic impact, for papers by Daniel Mathow Breakdown of academic impact, for papers by Nelson E. Bruno Breakdown of academic impact, for papers by Kelly Mundy Breakdown of academic impact, for papers by Zhenyuan Yu Breakdown of academic impact, for papers by Xiaowen Zhang
Rankless by CCL
2026